DCF — HANOVER HOSPITAL
Enterprise Value: $-16.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.5M
Enterprise Value
$-5.1M
PV of Cash Flows
$-11.4M
PV of Terminal Value
$-18.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $6.3M | $-1.1M | -17.0% | $-1.4M | $-1.2M |
| Year 2 | $6.5M | $-1.1M | -16.0% | $-1.3M | $-1.1M |
| Year 3 | $6.7M | $-1.0M | -15.0% | $-1.3M | $-1.0M |
| Year 4 | $6.9M | $-1.0M | -15.0% | $-1.3M | $-0.9M |
| Year 5 | $7.1M | $-1.0M | -15.0% | $-1.3M | $-0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$6.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1792849551205457
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5